Ironwood Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €110.88M -17.2% -€17.06M +5.3% -15.4% -0.033 pp N/A N/A
    (estimated) €133.91M -12.3% -€16.21M +26.7% -12.1% -0.037 pp N/A N/A
    (estimated) €152.68M -30.5% -€12.79M -136.0% -8.4% -0.25 pp N/A N/A
    (estimated) €219.72M -6.1% €35.55M +88.8% 16.2% +0.081 pp €83.76M +22.9% 38.1% +0.090 pp
    (estimated) €233.99M -21.9% €18.83M +2,409.1% 8.0% +0.078 pp €68.15M -22.9% 29.1% -0.0038 pp
    €299.74M -20.6% €750.60K -100.1% 0.3% +2.3 pp €88.44M -43.6% 29.5% -0.12 pp
    €377.63M +7.8% -€854.86M -672.5% -226.4% -2.7 pp €156.69M -32.9% 41.5% -0.25 pp
    €350.22M -0.8% €149.32M -66.9% 42.6% -0.85 pp €233.62M +4.5% 66.7% +0.033 pp
    €352.91M +6.2% €450.74M +397.7% 127.7% +1.0 pp €223.61M +53.6% 63.4% +0.20 pp
    €332.24M -9.1% €90.56M -793.3% 27.3% +0.31 pp €145.58M +852.8% 43.8% +0.40 pp
    €365.42M +23.6% -€13.06M -94.6% -3.6% +0.78 pp €15.28M -128.8% 4.2% +0.22 pp
    €295.67M +16.2% -€240.85M +141.5% -81.5% -0.42 pp -€53.11M -34.7% -18.0% +0.14 pp
    €254.41M +8.9% -€99.74M +43.1% -39.2% -0.094 pp -€81.33M -221.0% -32.0% -0.61 pp
    €233.67M +83.2% -€69.69M -42.7% -29.8% +0.66 pp €67.19M -176.6% 28.8% +0.98 pp
    €127.56M +95.7% -€121.69M -24.8% -95.4% +1.5 pp -€87.75M -32.3% -68.8% +1.3 pp
    €65.20M +234.1% -€161.73M -30.5% -248.1% +9.4 pp -€129.67M -42.4% -198.9% +9.5 pp
    €19.52M -84.8% -€232.70M +275.6% -1,192.3% -11 pp -€224.98M +373.9% -1,152.8% -11 pp
    €128.15M +128.1% -€61.94M +12.0% -48.3% +0.50 pp -€47.47M -15.1% -37.0% +0.62 pp
    €56.18M +50.2% -€55.32M +22.4% -98.5% +0.22 pp -€55.92M +29.4% -99.5% +0.16 pp
    €37.41M +21.5% -€45.19M -25.6% -120.8% +0.76 pp -€43.23M -107,927.7% -115.6% -1.2 pp
    €30.79M +62.5% -€60.72M +32.1% -197.2% +0.45 pp €40.09K -100.9% 0.1% +0.24 pp
    €18.95M +112.3% -€45.95M +2.1% -242.5% +2.6 pp -€4.49M +28.1% -23.7% +0.16 pp
    €8.93M -€44.99M -504.1% -€3.50M -39.3%

    Notifications